21 CFR 500.4 Under the FPLA: Interpreting the Statement of Identity and Practical Points

In U.S. federal regulations, the Fair Packaging and Labeling Act (FPLA) is intended to ensure that information on the packaging and labels of food and consumer products is accurate and not misleading, so that consumers can make informed purchasing choices. 21 CFR § 500.4 sets out the basic requirements, forms of expression and prohibitions for the “statement of identity” on the principal display panel of a consumer commodity. This article systematically interprets the key points of the provision and offers practical advice to help companies design compliant packaging and reduce risk. 1. Scope and core principles (the overall framework of § 500.4(a)–(c)) Key points: The statement of identity must appear on the “principal display panel” of the consumer commodity (usually the most prominent position on the front of the package). The statement should be a prominent feature of the principal display panel, with an easily readable type size and a clear position, and its lines should be arranged parallel to the base on which the package or product rests when displayed. The form of expression should follow one of three priority orders: the official name required by federal law or regulation; if that name is not available, the common or usual name of the commodity; in the absence of the above, a generic name or other appropriate descriptive term (for example, a statement that includes a functional description). Practical points: At the design stage, define the boundaries and available space of the “principal display panel” to ensure the readability and visual prominence of the statement of identity. For products involving regulatory names in multiple countries, check the current federal requirements for the “official name” to avoid misuse, misstatement or confusion. If the official name required by regulation cannot be used, evaluate the feasibility and potential compliance risks of substituting a common name, usual name or descriptive term. The font, size and contrast of the statement of identity should meet the company's internal accessibility standards, ensuring that people who are color-blind or have low vision can read it clearly. 2. The priority of the three forms of expression and alternative paths (the detail of § 500.4(c)) Specific paths: (1) First choice: use the “prescribed official name” (the statutory name, the name required by regulation). (2) Second choice: if the official name is not available, use the commodity's “common name” or “usual name.” (3) Alternative: if neither of the first two is feasible, use a “generic name or other appropriate descriptive term,” such as a statement that includes a functional description. Practical points: Before implementation, conduct a name-verifiability assessment: is there a clear statutory official name? Is there a common name recognized within the industry? When using the alternative path (descriptive terms), avoid creating misunderstanding, exaggerating efficacy or hiding important information. Descriptive terms should be as concise and objective as possible, and avoid implying non-existent attributes. For cross-category products, separately verify the applicable “official name” requirements for each, because different categories (such as food and non-food everyday goods) may have different naming conventions. 3. Prohibitions and exceptions (the core prohibition of § 500.4(d)) Prohibition points: The statement of identity must not be false, misleading or deceptive to consumers in any respect. It must not refer to a component or ingredient that is not present in the commodity in a substantial or significantly effective amount. Exception: If a component is present in the formulation in a substantial and effective amount, but is not present in its original form in the final product because it has been converted into another entity (and that entity is present in the final product), then the component may be mentioned in the statement of identity. Practical points: Cross-check the ingredient list against the “statement of identity” to exclude any reference to components that are not substantially present. If intermediates or a conversion process cause a component to appear in a different entity form in the final product, the way that component is presented and worded should be appropriately defined to avoid misleading consumers. For descriptive terms that include a “functional claim,” avoid equating the functional description with unproven efficacy. 4. Practical application and compliance advice Label design process: Place the “statement of identity” in a prominent position on the principal display panel at the design stage, ensuring high visual priority and strong readability. Use high contrast, clear fonts and a type size that meets readability requirements, arranged parallel to the base of the package. Clearly document a list of alternatives for the official name, common name, usual name and descriptive wording, so that compliance can be implemented quickly across different product lines and packaging versions. Documentation and evidence: Against current regulations and industry guidance, keep the regulatory basis for the official name, authoritative references for the industry common name, and supporting evidence for any descriptive statements (such as data sources for functional claims, clinical/experimental data, regulatory interpretation documents, etc.). Establish a change-management process: if regulations are updated or market requirements change, quickly assess and update the statement-of-identity text. Exceptions and communication: For products involving special materials or many functional claims, be prepared to explain externally, ensuring that customer service and the regulatory/compliance team communicate consistently. Review and compliance assessment: Establish an internal review mechanism that includes at least cross-review by legal/compliance, marketing and packaging design to ensure the text meets all the requirements of § 500.4. Before external release, run a compliance self-check covering: display position, type size, line arrangement, the accuracy of the name choice and description, ingredient disclosure and conversion situations. 5. Conclusion 21 CFR § 500.4 provides a clear framework for the statement of identity of consumer commodities: it emphasizes prominence, readability and the core principle of avoiding misleading information. At the packaging-design stage, companies should establish a clear name-selection path (official name → common/usual name → descriptive wording) and strictly control how the text is presented, ensuring the statement of identity is consistent with the actual attributes of the commodity. Through a systematic process, supporting evidence and multi-party review, compliance risk can be effectively reduced while increasing consumer trust in product information.